Citations (130)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Dongmei Zhang, Wen Li & Shibo Jiang. (2015) Peptide fusion inhibitors targeting the HIV-1 gp41: a patent review (2009 – 2014). Expert Opinion on Therapeutic Patents 25:2, pages 159-173.
Read now
Read now
Asim K Debnath. (2006) Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1. Expert Opinion on Investigational Drugs 15:5, pages 465-478.
Read now
Read now
Mark
A. Baumeister, Michael
A. Chattergoon & David
B. Weiner. (2002) Prospects for an HIV Vaccine: Conventional Approaches and DNA Immunization. Biotechnology and Genetic Engineering Reviews 19:1, pages 205-244.
Read now
Read now
Articles from other publishers (127)
Yue Hu, Wenjiang Yu, Xiuzhu Geng, Yuanmei Zhu, Huihui Chong & Yuxian He. (2022) In Vitro Selection and Characterization of HIV-1 Variants with Increased Resistance to LP-40, Enfuvirtide-Based Lipopeptide Inhibitor. International Journal of Molecular Sciences 23:12, pages 6638.
Crossref
Crossref
Lixiao Xing, Xinfeng Xu, Wei Xu, Zezhong Liu, Xin Shen, Jie Zhou, Ling Xu, Jing Pu, Chan Yang, Yuan Huang, Lu Lu, Shibo Jiang & Shuwen Liu. (2022) A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern. Viruses 14:3, pages 597.
Crossref
Crossref
Chao Wang, Shuai Xia, Xinling Wang, Yue Li, Huan Wang, Rong Xiang, Qinwen Jiang, Qiaoshuai Lan, Ruiying Liang, Qing Li, Shanshan Huo, Lu Lu, Qian Wang, Fei Yu, Keliang Liu & Shibo Jiang. (2021) Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human β-Coronavirus Infection. Journal of Medicinal Chemistry 65:4, pages 2809-2819.
Crossref
Crossref
Xinling Wang, Wei Xu, Zezhong Liu, Yanling Wu, Qian Wang, Miao Cao, Tianlei Ying, Na He, Lu Lu & Shibo Jiang. (2022) A Toxin-Conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-Reversing Agent-Reactivated Latent Cells. mBio 13:1.
Crossref
Crossref
Shan Su, Wei Xu & Shibo Jiang. 2022. Virus Entry Inhibitors. Virus Entry Inhibitors
1
13
.
Xinling Wang, Miao Cao, Yanling Wu, Wei Xu, Qian Wang, Tianlei Ying, Lu Lu & Shibo Jiang. (2021) Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection. Molecules 26:7, pages 1964.
Crossref
Crossref
Pu, Wang, Xu, Lu & Jiang. (2019) Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41. Viruses 11:8, pages 705.
Crossref
Crossref
Xiuzhu Geng, Zixuan Liu, Danwei Yu, Bo Qin, Yuanmei Zhu, Sheng Cui, Huihui Chong & Yuxian He. (2019) Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors. Viruses 11:7, pages 609.
Crossref
Crossref
Min Zhuang, Russell Vassell, Chen Yuan, Paul W. Keller, Hong Ling, Wei Wang & Carol D. Weiss. (2019) Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses. Journal of Virology 93:11.
Crossref
Crossref
Shuai Xia, Lei Yan, Wei Xu, Anurodh Shankar AgrawalAbdullah AlgaissiChien-Te K. TsengQian WangLanying DuWenjie TanIan A. Wilson, Shibo Jiang, Bei Yang & Lu Lu. (2019) A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Science Advances 5:4.
Crossref
Crossref
Shan Su, Giselle Rasquinha, Lanying Du, Qian Wang, Wei Xu, Weihua Li, Lu Lu & Shibo Jiang. (2019) A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life. Molecules 24:6, pages 1134.
Crossref
Crossref
Shuai Xia, Qiaoshuai Lan, Jing Pu, Cong Wang, Zezhong Liu, Wei Xu, Qian Wang, Huan Liu, Shibo Jiang & Lu Lu. (2019) Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4. Viruses 11:1, pages 56.
Crossref
Crossref
Olapeju Bolarinwa, Meng Zhang, Erin Mulry, Min Lu & Jianfeng Cai. (2018) Sulfono-γ-AA modified peptides that inhibit HIV-1 fusion. Organic & Biomolecular Chemistry 16:42, pages 7878-7882.
Crossref
Crossref
Huihui Chong, Yuanmei Zhu, Danwei Yu & Yuxian He. (2018) Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. Journal of Virology 92:20.
Crossref
Crossref
Huihui Chong, Jing Xue, Yuanmei Zhu, Zhe Cong, Ting Chen, Yan Guo, Qiang Wei, Yusen Zhou, Chuan Qin & Yuxian He. (2018) Design of Novel HIV-1/2 Fusion Inhibitors with High Therapeutic Efficacy in Rhesus Monkey Models. Journal of Virology 92:16.
Crossref
Crossref
Shan Su, Zhenxuan Ma, Chen Hua, Weihua Li, Lu Lu & Shibo Jiang. (2017) Adding an Artificial Tail—Anchor to a Peptide-Based HIV-1 Fusion Inhibitor for Improvement of Its Potency and Resistance Profile. Molecules 22:11, pages 1996.
Crossref
Crossref
Yu Bai, Chao Wang, Guodong Liang, Wenqing Lai, Huifang Xue, Yanbo Ling, Maosheng Cheng & Keliang Liu. (2017) Precisely Designed Isopeptide Bridge-Crosslinking Endows Artificial Hydrolases with High Stability and Catalytic Activity under Extreme Denaturing Conditions. Chemistry - An Asian Journal 12:19, pages 2539-2543.
Crossref
Crossref
Xiaohui Ding, Xiujuan Zhang, Huihui Chong, Yuanmei Zhu, Huamian Wei, Xiyuan Wu, Jinsheng He, Xinquan Wang & Yuxian He. (2017) Enfuvirtide (T20)-Based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implications for Viral Entry and Inhibition. Journal of Virology 91:18.
Crossref
Crossref
Shan Su, Yun Zhu, Sheng Ye, Qianqian Qi, Shuai Xia, Zhenxuan Ma, Fei Yu, Qian Wang, Rongguang Zhang, Shibo Jiang & Lu Lu. (2017) Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors. Journal of Virology 91:1.
Crossref
Crossref
Mukta D. Khasnis, Konstantine Halkidis, Anshul Bhardwaj & Michael J. Root. (2016) Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer. PLOS Pathogens 12:12, pages e1006098.
Crossref
Crossref
Xifeng Jiang, Qiyan Jia, Lu Lu, Fei Yu, Jishen Zheng, Weiguo Shi, Lifeng Cai, Shibo Jiang & Keliang Liu. (2016) A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41. Amino Acids 48:12, pages 2867-2873.
Crossref
Crossref
Lihong Liu, Xiaoying Xu, Yanhui Liu, Xuanxuan Zhang, Lin Li & Zhimin Jia. (2016) Screening HIV-1 fusion inhibitors based on capillary electrophoresis head-end microreactor targeting to the core structure of gp41. Journal of Pharmaceutical and Biomedical Analysis 120, pages 153-157.
Crossref
Crossref
Shidong Chu, Hardeep Kaur, Ariana Nemati, Joseph D. Walsh, Vivian Partida, Shao-Qing Zhang & Miriam Gochin. (2015) Swapped-Domain Constructs of the Glycoprotein-41 Ectodomain Are Potent Inhibitors of HIV Infection. ACS Chemical Biology 10:5, pages 1247-1257.
Crossref
Crossref
Joseph D. Walsh, Shidong Chu, Shao-Qing Zhang & Miriam Gochin. (2015) Design and characterization of swapped-domain constructs of HIV-1 glycoprotein-41 as receptors for drug discovery. Protein Engineering, Design and Selection 28:4, pages 107-116.
Crossref
Crossref
Sara CrespilloAna Cámara-ArtigasSalvador CasaresBertrand MorelEva S. CobosPedro L. MateoNicolas MouzChristophe E. MartinMarie G. RogerRaphaelle El Habib, Bin Su, Christiane Moog & Francisco Conejero-Lara. (2014) Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti–HIV-1 drugs. Proceedings of the National Academy of Sciences 111:51, pages 18207-18212.
Crossref
Crossref
Xueting Ma, Jianjun Tan, Min Su, Chunhua Li, Xiaoyi Zhang & Cunxin Wang. (2014) Molecular Dynamics Studies of the Inhibitor C34 Binding to the Wild-Type and Mutant HIV-1 gp41: Inhibitory and Drug Resistant Mechanism. PLoS ONE 9:11, pages e111923.
Crossref
Crossref
Huihui Chong, Xue Yao, Zonglin Qiu, Jianping Sun, Yuanyuan Qiao, Meng Zhang, Meitian Wang, Sheng Cui & Yuxian He. (2014) The M-T hook structure increases the potency of HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance. Journal of Antimicrobial Chemotherapy 69:10, pages 2759-2769.
Crossref
Crossref
Fei Yu, Lu Lu, Qi Liu, Xiaowen Yu, Lili Wang, Elaine He, Peng Zou, Lanying Du, Rogier W. Sanders, Shuwen Liu & Shibo Jiang. (2014) ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer. Biochimica et Biophysica Acta (BBA) - Biomembranes 1838:5, pages 1296-1305.
Crossref
Crossref
Teena Mohan, Priyanka Verma & D.N. Rao. (2014) Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides. Immunobiology 219:4, pages 292-301.
Crossref
Crossref
Lu Lu, Qi Liu, Yun Zhu, Kwok-Hung Chan, Lili Qin, Yuan Li, Qian Wang, Jasper Fuk-Woo Chan, Lanying Du, Fei Yu, Cuiqing Ma, Sheng Ye, Kwok-Yung Yuen, Rongguang Zhang & Shibo Jiang. (2014) Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nature Communications 5:1.
Crossref
Crossref
Minmin LiJiangman DuanJiayin QiuFei YuXiaoyan CheShibo JiangLin Li. (2013) 3-Hydroxyphthalic Anhydride-Modified Human Serum Albumin as a Microbicide Candidate Against HIV Type 1 Entry by Targeting Both Viral Envelope Glycoprotein gp120 and Cellular Receptor CD4. AIDS Research and Human Retroviruses 29:11, pages 1455-1464.
Crossref
Crossref
Lijun Chao, Lu Lu, Hengwen Yang, Yun Zhu, Yuan Li, Qian Wang, Xiaowen Yu, Shibo Jiang & Ying-Hua Chen. (2013) Identification of a Human Protein-Derived HIV-1 Fusion Inhibitor Targeting the gp41 Fusion Core Structure. PLoS ONE 8:5, pages e66156.
Crossref
Crossref
Yu Bai, Huifang Xue, Kun Wang, Lifeng Cai, Jiayin Qiu, Shuangyu Bi, Luhua Lai, Maosheng Cheng, Shuwen Liu & Keliang Liu. (2012) Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket. Amino Acids 44:2, pages 701-713.
Crossref
Crossref
Kristin Eissmann, Sebastian Mueller, Heinrich Sticht, Susan Jung, Peng Zou, Shibo Jiang, Andrea Gross, Jutta Eichler, Bernhard Fleckenstein & Heide Reil. (2013) HIV-1 Fusion Is Blocked through Binding of GB Virus C E2D Peptides to the HIV-1 gp41 Disulfide Loop. PLoS ONE 8:1, pages e54452.
Crossref
Crossref
Fei Yu, Lu Lu, Lanying Du, Xiaojie Zhu, Asim Debnath & Shibo Jiang. (2013) Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket. Viruses 5:1, pages 127-149.
Crossref
Crossref
Christopher De Feo & Carol Weiss. (2012) Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors. Viruses 4:12, pages 3859-3911.
Crossref
Crossref
Lu Lu, Chungen Pan, Yuan Li, Hong Lu, Wu He & Shibo Jiang. (2012) A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains. Retrovirology 9:1.
Crossref
Crossref
Lu Lu, Pei Tong, Xiaowen Yu, Chungen Pan, Peng Zou, Ying-Hua Chen & Shibo Jiang. (2012) HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain. Biochimica et Biophysica Acta (BBA) - Biomembranes 1818:12, pages 2950-2957.
Crossref
Crossref
Xuebo Hu, Piyali Saha, Xiaoyue Chen, Dogeun Kim, Mahesh Devarasetty, Raghavan Varadarajan & Moonsoo M. Jin. (2012) Cell Surface Assembly of HIV gp41 Six-Helix Bundles for Facile, Quantitative Measurements of Hetero-oligomeric Interactions. Journal of the American Chemical Society 134:36, pages 14642-14645.
Crossref
Crossref
Rui Gong, Weizao Chen & Dimiter S. Dimitrov. (2012) Candidate Antibody-Based Therapeutics Against HIV-1. BioDrugs 26:3, pages 143-162.
Crossref
Crossref
Tai An, Wenjie Ouyang, Wei Pan, Deyin Guo, Jurong Li, Longlong Li, Gang Chen, Jian Yang, Shuwen Wu & Po Tien. (2012) Amino acid derivatives of the (−) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1. Antiviral Research 94:3, pages 276-287.
Crossref
Crossref
Min Zhuang, Wei Wang, Christopher J. De Feo, Russell Vassell & Carol D. Weiss. (2012) Trimeric, Coiled-coil Extension on Peptide Fusion Inhibitor of HIV-1 Influences Selection of Resistance Pathways. Journal of Biological Chemistry 287:11, pages 8297-8309.
Crossref
Crossref
Fusako Miyamoto & Eiichi N Kodama. (2012) Novel HIV-1 Fusion Inhibition Peptides: Designing the Next Generation of Drugs. Antiviral Chemistry and Chemotherapy 22:4, pages 151-158.
Crossref
Crossref
Xiaowen Yu, Lu Lu, Lifeng Cai, Pei Tong, Suiyi Tan, Peng Zou, Fanxia Meng, Ying-hua Chen & Shibo Jiang. (2012) Mutations of Gln64 in the HIV-1 gp41 N-Terminal Heptad Repeat Render Viruses Resistant to Peptide HIV Fusion Inhibitors Targeting the gp41 Pocket. Journal of Virology 86:1, pages 589-593.
Crossref
Crossref
Yu Bai, Huifang Xue, Yanbo Ling, Maosheng Cheng, Lifeng Cai & Keliang Liu. (2012) Inter-chain acyl transfer reaction in a peptide six-helical bundle: a chemical method for regulating the interaction between peptides or proteins. Chemical Communications 48:36, pages 4320.
Crossref
Crossref
Yu Bai, Yanbo Ling, Weiguo Shi, Lifeng Cai, Qiyan Jia, Shibo Jiang & Keliang Liu. (2011) Heteromeric Assembled Polypeptidic Artificial Hydrolases with a Six-Helical Bundle Scaffold. ChemBioChem 12:17, pages 2647-2658.
Crossref
Crossref
Sheng-He HuangChu-Hua WuShibo Jiang, Ingrid BahnerAlbert S. LossinskyAmbrose Y. Jong. (2011)
HIV-1 gp41 ectodomain enhances
Cryptococcus neoformans
binding to human brain microvascular endothelial cells via gp41 core-induced membrane activities
. Biochemical Journal 438:3, pages 457-466.
Crossref
Crossref
Yan Liu, Zhuofeng Ke, Kwok Yiu Wu, Shuwen Liu, Wen-Hua Chen, Shibo Jiang & Zhi-Hong Jiang. (2011) An Amphiphilic Conjugate Approach toward the Design and Synthesis of Betulinic Acid-Polyphenol Conjugates as Inhibitors of the HIV-1 gp41 Fusion Core Formation. ChemMedChem 6:9, pages 1654-1664.
Crossref
Crossref
Hyun Ah Yi, Barbara Diaz-Aguilar, Dominique Bridon, Omar Quraishi & Amy Jacobs. (2011) Permanent Inhibition of Viral Entry by Covalent Entrapment of HIV gp41 on the Virus Surface. Biochemistry 50:32, pages 6966-6972.
Crossref
Crossref
Bo Zhao, Marie K. Mankowski, Beth A. Snyder, Roger G. Ptak & Patricia J. LiWang. (2011) Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry. Journal of Biological Chemistry 286:32, pages 28370-28381.
Crossref
Crossref
S. Shang, S. Tan, K. Li, J. Wu, H. Lin, S. Liu & Y. Deng. (2011) Glu659Leu substitution of recombinant HIV fusion inhibitor C52L induces soluble expression in Escherichia coli with equivalent anti-HIV potency. Protein Engineering Design and Selection 24:7, pages 545-551.
Crossref
Crossref
Ioannis Kagiampakis, Arbi Gharibi, Marie K. Mankowski, Beth A. Snyder, Roger G. Ptak, Kristabelle Alatas & Patricia J. LiWang. (2011) Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41. Antimicrobial Agents and Chemotherapy 55:1, pages 264-275.
Crossref
Crossref
Jorge Becerril, Johanna M. Rodriguez, Pauline N. Wyrembak & Andrew D. Hamilton. 2010. Protein Surface Recognition. Protein Surface Recognition
105
131
.
Xi Chen, Lu Lu, Zhi Qi, Hong Lu, Ji Wang, Xiaoxia Yu, Yinghua Chen & Shibo Jiang. (2010) Novel Recombinant Engineered gp41 N-terminal Heptad Repeat Trimers and Their Potential as Anti-HIV-1 Therapeutics or Microbicides. Journal of Biological Chemistry 285:33, pages 25506-25515.
Crossref
Crossref
Kazuki Izumi, Shota Nakamura, Hiroaki Nakano, Kazuya Shimura, Yasuko Sakagami, Shinya Oishi, Susumu Uchiyama, Tadayasu Ohkubo, Yuji Kobayashi, Nobutaka Fujii, Masao Matsuoka & Eiichi N. Kodama. (2010) Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat. Antiviral Research 87:2, pages 179-186.
Crossref
Crossref
Lei Jin, Chungen Pan, Zhi Qi, Z. Hong Zhou & Shibo Jiang. (2010) Fab crystallization and preliminary X-ray analysis of NC-1, an anti-HIV-1 antibody that recognizes the six-helix bundle core of gp41. Acta Crystallographica Section F Structural Biology and Crystallization Communications 66:7, pages 854-857.
Crossref
Crossref
Lin Li, Lili He, Suiyi Tan, Xinhua Guo, Hong Lu, Zhi Qi, Chungen Pan, Xiuli An, Shibo Jiang & Shuwen Liu. (2010) 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin Exhibits Potent and Broad Anti-HIV-1 Activity: a Potential Microbicide for Preventing Sexual Transmission of HIV-1. Antimicrobial Agents and Chemotherapy 54:5, pages 1700-1711.
Crossref
Crossref
Chungen Pan, Shuwen Liu & Shibo Jiang. (2010) HIV-1 gp41 Fusion Intermediate: A Target for HIV Therapeutics. Journal of the Formosan Medical Association 109:2, pages 94-105.
Crossref
Crossref
Jie Liu, Yiqun Deng, Qunnu Li, Antu K. Dey, John P. Moore & Min Lu. (2010) Role of a Putative gp41 Dimerization Domain in Human Immunodeficiency Virus Type 1 Membrane Fusion. Journal of Virology 84:1, pages 201-209.
Crossref
Crossref
Hongtao Wang, Zhi Qi, Angi Guo, Qinchao Mao, Hong Lu, Xiuli An, Chenglai Xia, Xiaojuan Li, Asim K. Debnath, Shuguang Wu, Shuwen Liu & Shibo Jiang. (2009) ADS-J1 Inhibits Human Immunodeficiency Virus Type 1 Entry by Interacting with the gp41 Pocket Region and Blocking Fusion-Active gp41 Core Formation. Antimicrobial Agents and Chemotherapy 53:12, pages 4987-4998.
Crossref
Crossref
Ling Yue, Liang Shang & Eric Hunter. (2009) Truncation of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Defines Elements Required for Fusion, Incorporation, and Infectivity. Journal of Virology 83:22, pages 11588-11598.
Crossref
Crossref
Vijay Sivaraman, Liguo Zhang, Eric G. Meissner, Jerry L. Jeffrey & Lishan Su. (2009) The Heptad Repeat 2 Domain Is a Major Determinant for Enhanced Human Immunodeficiency Virus Type 1 (HIV-1) Fusion and Pathogenicity of a Highly Pathogenic HIV-1 Env. Journal of Virology 83:22, pages 11715-11725.
Crossref
Crossref
Lifeng Cai, Edina Balogh & Miriam Gochin. (2009) Stable Extended Human Immunodeficiency Virus Type 1 gp41 Coiled Coil as an Effective Target in an Assay for High-Affinity Fusion Inhibitors. Antimicrobial Agents and Chemotherapy 53:6, pages 2444-2449.
Crossref
Crossref
Takeshi Naito, Kazuki Izumi, Eiichi Kodama, Yasuko Sakagami, Keiko Kajiwara, Hiroki Nishikawa, Kentaro Watanabe, Stefan G. Sarafianos, Shinya Oishi, Nobutaka Fujii & Masao Matsuoka. (2009) SC29EK, a Peptide Fusion Inhibitor with Enhanced α-Helicity, Inhibits Replication of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide. Antimicrobial Agents and Chemotherapy 53:3, pages 1013-1018.
Crossref
Crossref
Jing Li, Xi Chen, Jinghe Huang, Shibo Jiang & Ying-Hua Chen. (2009) Identification of critical antibody-binding sites in the HIV-1 gp41 six-helix bundle core as potential targets for HIV-1 fusion inhibitors. Immunobiology 214:1, pages 51-60.
Crossref
Crossref
Yuxian He, Shuwen Liu, Jingjing Li, Hong Lu, Zhi Qi, Zhonghua Liu, Asim K. Debnath & Shibo Jiang. (2008) Conserved Salt Bridge between the N- and C-Terminal Heptad Repeat Regions of the Human Immunodeficiency Virus Type 1 gp41 Core Structure Is Critical for Virus Entry and Inhibition. Journal of Virology 82:22, pages 11129-11139.
Crossref
Crossref
Zhi Qi, Weiguo Shi, Na Xue, Chungen Pan, Weiguo Jing, Keliang Liu & Shibo Jiang. (2008) Rationally Designed Anti-HIV Peptides Containing Multifunctional Domains as Molecule Probes for Studying the Mechanisms of Action of the First and Second Generation HIV Fusion Inhibitors. Journal of Biological Chemistry 283:44, pages 30376-30384.
Crossref
Crossref
Weiguo Shi, Zhi Qi, Chungen Pan, Na Xue, Asim K. Debnath, Jiankun Qie, Shibo Jiang & Keliang Liu. (2008) Novel anti-HIV peptides containing multiple copies of artificially designed heptad repeat motifs. Biochemical and Biophysical Research Communications 374:4, pages 767-772.
Crossref
Crossref
Dirk Eggink, Christopher E. Baldwin, Yiqun Deng, Johannes P. M. Langedijk, Min Lu, Rogier W. Sanders & Ben Berkhout. (2008) Selection of T1249-Resistant Human Immunodeficiency Virus Type 1 Variants. Journal of Virology 82:13, pages 6678-6688.
Crossref
Crossref
Yuxian He, Jianwei Cheng, Jingjing Li, Zhi Qi, Hong Lu, Mingxin Dong, Shibo Jiang & Qiuyun Dai. (2008) Identification of a Critical Motif for the Human Immunodeficiency Virus Type 1 (HIV-1) gp41 Core Structure: Implications for Designing Novel Anti-HIV Fusion Inhibitors. Journal of Virology 82:13, pages 6349-6358.
Crossref
Crossref
Lu Lu, Yun Zhu, Jinghe Huang, Xi Chen, Hengwen Yang, Shibo Jiang & Ying-Hua Chen. (2008) Surface Exposure of the HIV-1 Env Cytoplasmic Tail LLP2 Domain during the Membrane Fusion Process. Journal of Biological Chemistry 283:24, pages 16723-16731.
Crossref
Crossref
Géry Dams, Koen Van Acker, Emmanuel Gustin, Inge Vereycken, Lieve Bunkens, Pascale Holemans, Liesbet Smeulders, Reginald Clayton, Asa Ohagen & Kurt Hertogs. (2007) A Time-Resolved Fluorescence Assay to Identify Small-Molecule Inhibitors of HIV-1 Fusion. SLAS Discovery 12:6, pages 865-874.
Crossref
Crossref
Shuwen Liu, Weiguo Jing, Byron Cheung, Hong Lu, Jane Sun, Xuxia Yan, Jinkui Niu, James Farmar, Shuguang Wu & Shibo Jiang. (2007) HIV gp41 C-terminal Heptad Repeat Contains Multifunctional Domains. Journal of Biological Chemistry 282:13, pages 9612-9620.
Crossref
Crossref
Jing-He Huang, Lu Lu, Hong Lu, Xi Chen, Shibo Jiang & Ying-Hua Chen. (2007) Identification of the HIV-1 gp41 Core-binding Motif in the Scaffolding Domain of Caveolin-1. Journal of Biological Chemistry 282:9, pages 6143-6152.
Crossref
Crossref
Antonis Mirsaliotis, Kulpash Nurkiyanova, Daniel Lamb, Chien-Wen S. Kuo & David W. Brighty. (2007) An antibody that blocks human T-cell leukemia virus type 1 six-helix-bundle formation in vitro identified by a novel assay for inhibitors of envelope function. Journal of General Virology 88:2, pages 660-669.
Crossref
Crossref
Wang Wei & Carol D. Weiss. 2007. Entry Inhibitors in HIV Therapy. Entry Inhibitors in HIV Therapy
79
97
.
Ofir Korazim, Kelly Sackett & Yechiel Shai. (2006) Functional and Structural Characterization of HIV-1 gp41 Ectodomain Regions in Phospholipid Membranes Suggests that the Fusion-active Conformation Is Extended. Journal of Molecular Biology 364:5, pages 1103-1117.
Crossref
Crossref
Zheng ChenLiu HongZengshan LiDaiming FanQingsheng HuangHaitao WangZhidong LiZhikai Xu. (2006) Preparation and Characterization of Four Novel Monoclonal Antibodies Specific to N51(L6)C46 Polypeptide Simulating Fusogenic Core Structure of GP41 Subunit of HIV-1. Hybridoma 25:5, pages 278-282.
Crossref
Crossref
Jing-He Huang, Zu-Qiang Liu, Shuwen Liu, Shibo Jiang & Ying-Hua Chen. (2006) Identification of the HIV-1 gp41 core-binding motif - HXXNPF. FEBS Letters 580:20, pages 4807-4814.
Crossref
Crossref
Kelly Sackett, Yael Wexler-Cohen & Yechiel Shai. (2006) Characterization of the HIV N-terminal Fusion Peptide-containing Region in Context of Key gp41 Fusion Conformations. Journal of Biological Chemistry 281:31, pages 21755-21762.
Crossref
Crossref
Ling Ni, Linqing Zhao, Yuan Qian, Jieqing Zhu, Zhibo Jin, Yu Wai Chen, Po Tien & George F Gao. (2005) Design and Characterization of Human Respiratory Syncytial Virus Entry Inhibitors. Antiviral Therapy 10:7, pages 833-840.
Crossref
Crossref
Kelly Sackett & Yechiel Shai. (2005) The HIV Fusion Peptide Adopts Intermolecular Parallel β-Sheet Structure in Membranes when Stabilized by the Adjacent N-Terminal Heptad Repeat: A 13C FTIR Study. Journal of Molecular Biology 350:4, pages 790-805.
Crossref
Crossref
Ling Ni, George F. Gao & Po Tien. (2005) Rational design of highly potent HIV-1 fusion inhibitory proteins: Implication for developing antiviral therapeutics. Biochemical and Biophysical Research Communications 332:3, pages 831-836.
Crossref
Crossref
Shuwen Liu, Hong Lu, Jinkui Niu, Yujia Xu, Shuguang Wu & Shibo Jiang. (2005) Different from the HIV Fusion Inhibitor C34, the Anti-HIV Drug Fuzeon (T-20) Inhibits HIV-1 Entry by Targeting Multiple Sites in gp41 and gp120. Journal of Biological Chemistry 280:12, pages 11259-11273.
Crossref
Crossref
Christian Scholz, Peter Schaarschmidt, Alfred Michael Engel, Herbert Andres, Urban Schmitt, Elke Faatz, Jochen Balbach & Franz Xaver Schmid. (2005) Functional Solubilization of Aggregation-prone HIV Envelope Proteins by Covalent Fusion with Chaperone Modules. Journal of Molecular Biology 345:5, pages 1229-1241.
Crossref
Crossref
Shibo Jiang, Pamela Siddiqui & Shuwen Liu. (2004) Blocking viral entry: a complementary strategy for HIV therapy. Drug Discovery Today: Therapeutic Strategies 1:4, pages 497-503.
Crossref
Crossref
Shibo Jiang, Hong Lu, Shuwen Liu, Qian Zhao, Yuxian He & Asim K. Debnath. (2004) N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion. Antimicrobial Agents and Chemotherapy 48:11, pages 4349-4359.
Crossref
Crossref
Kelly R. YoungBenjamin E. TealYvonne BrooksThomas D. GreenJoseph F. BowerTed M. Ross. (2004) Unique V3 Loop Sequence Derived from the R2 Strain of HIV-Type 1 Elicits Broad Neutralizing Antibodies. AIDS Research and Human Retroviruses 20:11, pages 1259-1268.
Crossref
Crossref
Qian Zhao, Yuxian He, Gabriel Alespeiti & Asim Kumar Debnath. (2004) A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5. Virology 326:2, pages 299-309.
Crossref
Crossref
Stephen A. Gallo, Kelly Sackett, Satinder S. Rawat, Yechiel Shai & Robert Blumenthal. (2004) The Stability of the Intact Envelope Glycoproteins is a Major Determinant of Sensitivity of HIV/SIV to Peptidic Fusion Inhibitors. Journal of Molecular Biology 340:1, pages 9-14.
Crossref
Crossref
Wen Yuan, Stewart Craig, Zhihai Si, Michael Farzan & Joseph Sodroski. (2004) CD4-Induced T-20 Binding to Human Immunodeficiency Virus Type 1 gp120 Blocks Interaction with the CXCR4 Coreceptor. Journal of Virology 78:10, pages 5448-5457.
Crossref
Crossref
Sophie Shnaper, Kelly Sackett, Stephen A. Gallo, Robert Blumenthal & Yechiel Shai. (2004) The C- and the N-terminal Regions of Glycoprotein 41 Ectodomain Fuse Membranes Enriched and Not Enriched with Cholesterol, Respectively. Journal of Biological Chemistry 279:18, pages 18526-18534.
Crossref
Crossref
Eve de Rosny, Russell Vassell, Shibo Jiang, Renate Kunert & Carol D. Weiss. (2004) Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational Changes. Journal of Virology 78:5, pages 2627-2631.
Crossref
Crossref
Shuwen Liu, Louise Boyer-Chatenet, Hong Lu & Shibo Jiang. (2003) Rapid and Automated Fluorescence-Linked Immunosorbent Assay for High-Throughput Screening of Hiv-1 Fusion Inhibitors Targeting gp41. SLAS Discovery 8:6, pages 685-693.
Crossref
Crossref
Qian Zhao, Hong Lu, Dominique Schols, Erik De Clercq & Shibo Jiang. (2003) Development of a Cell-Based Enzyme-Linked Immunosorbent Assay for High-Throughput Screening of HIV Type 1 Entry Inhibitors Targeting the Coreceptor CXCR4. AIDS Research and Human Retroviruses 19:11, pages 947-955.
Crossref
Crossref
Shuwen Liu, Qian Zhao & Shibo Jiang. (2003) Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitors. Peptides 24:9, pages 1303-1313.
Crossref
Crossref
Nicole R. Kilgore, Karl Salzwedel, Mary Reddick, Graham P. Allaway & Carl T. Wild. (2003) Direct Evidence that C-Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Entry Bind to the gp41 N-Helical Domain in Receptor-Activated Viral Envelope. Journal of Virology 77:13, pages 7669-7672.
Crossref
Crossref
Hong Lu, Qian Zhao, Zhikai Xu & Shibo Jiang. (2003) Automatic quantitation of HIV-1 mediated cell-to-cell fusion with a digital image analysis system (DIAS): application for rapid screening of HIV-1 fusion inhibitors. Journal of Virological Methods 107:2, pages 155-161.
Crossref
Crossref
Shi-Hua Xiang, Peter D. Kwong, Rishi Gupta, Carlo D. Rizzuto, David J. Casper, Richard Wyatt, Liping Wang, Wayne A. Hendrickson, Michael L. Doyle & Joseph Sodroski. (2002) Mutagenic Stabilization and/or Disruption of a CD4-Bound State Reveals Distinct Conformations of the Human Immunodeficiency Virus Type 1 gp120 Envelope Glycoprotein. Journal of Virology 76:19, pages 9888-9899.
Crossref
Crossref
Ruben M. Markosyan, Xiuwen Ma, Min Lu, Fredric S. Cohen & Grigory B. Melikyan. (2002) The Mechanism of Inhibition of HIV-1 Env-Mediated Cell–Cell Fusion by Recombinant Cores of gp41 Ectodomain. Virology 302:1, pages 174-184.
Crossref
Crossref
Kathryn E. Follis, Scott J. Larson, Min Lu & Jack H. Nunberg. (2002) Genetic Evidence that Interhelical Packing Interactions in the gp41 Core Are Critical for Transition of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein to the Fusion-Active State. Journal of Virology 76:14, pages 7356-7362.
Crossref
Crossref
Hana Golding, Marina Zaitseva, Eve de Rosny, Lisa R. King, Jody Manischewitz, Igor Sidorov, Miroslaw K. Gorny, Susan Zolla-Pazner, Dimiter S. Dimitrov & Carol D. Weiss. (2002) Dissection of Human Immunodeficiency Virus Type 1 Entry with Neutralizing Antibodies to gp41 Fusion Intermediates. Journal of Virology 76:13, pages 6780-6790.
Crossref
Crossref
Annette Alfsen & Morgane Bomsel. (2002) HIV-1 gp41 Envelope Residues 650–685 Exposed on Native Virus Act as a Lectin to Bind Epithelial Cell Galactosyl Ceramide. Journal of Biological Chemistry 277:28, pages 25649-25659.
Crossref
Crossref
Bimal K. Chakrabarti, Wing-pui Kong, Bei-yue Wu, Zhi-Yong Yang, Jacques Friborg, Xu Ling, Steven R. King, David C. Montefiori & Gary J. Nabel. (2002) Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic Immunization. Journal of Virology 76:11, pages 5357-5368.
Crossref
Crossref
Jie Liu, Shilong Wang, James A. Hoxie, Celia C. LaBranche & Min Lu. (2002) Mutations That Destabilize the gp41 Core Are Determinants for Stabilizing the Simian Immunodeficiency Virus-CPmac Envelope Glycoprotein Complex. Journal of Biological Chemistry 277:15, pages 12891-12900.
Crossref
Crossref
Larry M. Gordon, Patrick W. Mobley, Rosemarie Pilpa, Mark A. Sherman & Alan J. Waring. (2002) Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using 13C-enhanced Fourier transform infrared spectroscopy. Biochimica et Biophysica Acta (BBA) - Biomembranes 1559:2, pages 96-120.
Crossref
Crossref
Justin T. Ernst, Olaf Kutzki, Asim K. Debnath, Shibo Jiang, Hong Lu & Andrew D. Hamilton. (2002) Design of a Protein Surface Antagonist Based onα-Helix Mimicry: Inhibition of gp41 Assembly and Viral Fusion. Angewandte Chemie 114:2, pages 288-291.
Crossref
Crossref
Min Lu, Marisa O. Stoller, Shilong Wang, Jie Liu, Melinda B. Fagan & Jack H. Nunberg. (2001) Structural and Functional Analysis of Interhelical Interactions in the Human Immunodeficiency Virus Type 1 gp41 Envelope Glycoprotein by Alanine-Scanning Mutagenesis. Journal of Virology 75:22, pages 11146-11156.
Crossref
Crossref
Debra M. Eckert & Peter S. Kim. (2001) Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region. Proceedings of the National Academy of Sciences 98:20, pages 11187-11192.
Crossref
Crossref
Debra M. EckertPeter S. Kim. (2001) Mechanisms of Viral Membrane Fusion and Its Inhibition. Annual Review of Biochemistry 70:1, pages 777-810.
Crossref
Crossref
Patrick W. MobleyRosemarie PilpaCraig BrownAlan J. WaringLarry M. Gordon. (2001) Membrane-Perturbing Domains of HIV Type 1 Glycoprotein 41. AIDS Research and Human Retroviruses 17:4, pages 311-327.
Crossref
Crossref
Ilian Jelesarov & Min Lu. (2001) Thermodynamics of trimer-of-hairpins formation by the SIV gp41 envelope protein11Edited by I. B. Holland. Journal of Molecular Biology 307:2, pages 637-656.
Crossref
Crossref
Shunji Matsuda & Masahiro Noda. (2013) Detection of IgA‐Binding Sites on Human Immunodeficiency Virus Type‐1 Envelope Glycoproteins, Gp120 and Gp41. Microbiology and Immunology 44:11, pages 923-929.
Crossref
Crossref
Yingying Le, Shibo Jiang, Jinyue Hu, Wanghua Gong, Shaobo Su, Nancy M. Dunlop, Weiping Shen, Baoqun Li & Ji Ming Wang. (2000) N36, a Synthetic N-Terminal Heptad Repeat Domain of the HIV-1 Envelope Protein gp41, Is an Activator of Human Phagocytes. Clinical Immunology 96:3, pages 236-242.
Crossref
Crossref
Yossef Kliger, Sergio Gerardo Peisajovich, Robert Blumenthal & Yechiel Shai. (2000) Membrane-induced conformational change during the activation of HIV-1 gp41 1 1Edited by A. R. Fersht. Journal of Molecular Biology 301:4, pages 905-914.
Crossref
Crossref
YVES CHAPRON, JEAN-MICHEL PEYRIN, SERGE CROUZY, ALEXANDRE JAEGLY & DOMINIQUE DORMONT. (2000) Theoretical Analysis of the Implication of PrP in Neuronal Death during Transmissible Subacute Spongiform Encephalopathies: Hypothesis of a PrP Oligomeric Channel. Journal of Theoretical Biology 204:1, pages 103-111.
Crossref
Crossref
Wei Shu, Hong Ji & Min Lu. (2000) Interactions between HIV-1 gp41 Core and Detergents and Their Implications for Membrane Fusion. Journal of Biological Chemistry 275:3, pages 1839-1845.
Crossref
Crossref
Yossef Kliger & Yechiel Shai. (2000) Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation. Journal of Molecular Biology 295:2, pages 163-168.
Crossref
Crossref
Hong Ji, Wei Shu, F. Temple Burling, Shibo Jiang & Min Lu. (1999) Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by the gp41 Core: Role of a Conserved Hydrophobic Cavity in Membrane Fusion. Journal of Virology 73:10, pages 8578-8586.
Crossref
Crossref
Debra M. Eckert, Vladimir N. Malashkevich, Lily H. Hong, Peter A. Carr & Peter S. Kim. (1999) Inhibiting HIV-1 Entry. Cell 99:1, pages 103-115.
Crossref
Crossref
Eun Ju Park & Gerald V. QuinnanJr.Jr.. (1999) Both Neutralization Resistance and High Infectivity Phenotypes Are Caused by Mutations of Interacting Residues in the Human Immunodeficiency Virus Type 1 gp41 Leucine Zipper and the gp120 Receptor- and Coreceptor-Binding Domains. Journal of Virology 73:7, pages 5707-5713.
Crossref
Crossref
Shibo Jiang, Kang Lin, Li Zhang & Asim K Debnath. (1999) A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody. Journal of Virological Methods 80:1, pages 85-96.
Crossref
Crossref
Min Lu, Hong Ji & Steven Shen. (1999) Subdomain Folding and Biological Activity of the Core Structure from Human Immunodeficiency Virus Type 1 gp41: Implications for Viral Membrane Fusion. Journal of Virology 73:5, pages 4433-4438.
Crossref
Crossref
A. M. Schultz. 1999. Vaccines. Vaccines
357
396
.
David C. Chan, Christine T. Chutkowski & Peter S. Kim. (1998) Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proceedings of the National Academy of Sciences 95:26, pages 15613-15617.
Crossref
Crossref
Shibo Jiang, Kang Lin & Min Lu. (1998) A Conformation-Specific Monoclonal Antibody Reacting with Fusion-Active gp41 from the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein. Journal of Virology 72:12, pages 10213-10217.
Crossref
Crossref
Vladimir N. Malashkevich, David C. Chan, Christine T. Chutkowski & Peter S. Kim. (1998) Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proceedings of the National Academy of Sciences 95:16, pages 9134-9139.
Crossref
Crossref